Table 4.

Responses on prioritising ventilator allocation regarding clinical presentation of COVID-19.

Factor	Low priority (%)	Equal priority (%)	High priority (%)	Mean (SD)	95% CI	Median (IQR)	Skewness
Frailty scale
Very fit	2 (5.7)	8 (22.9)	25 (71.4)	0.7 (0.6)	0.5, 0.9	1 (0, 1)	−1.6
Well	3 (8.6)	7 (20.0)	25 (71.4)	0.6 (0.6)	0.4, 0.9	1 (0, 1)	−1.6
Managing well	1 (2.9)	11 (31.4)	23 (65.7)	0.6 (0.5)	0.4, 0.8	1 (0, 1)	−1.1
Vulnerable	2 (5.7)	12 (34.3)	21 (60.0)	0.5 (0.6)	0.3, 0.8	1 (0, 1)	−1.0
Mildly frail	6 (17.1)	10 (28.6)	19 (54.3)	0.4 (0.8)	0.1, 0.6	1 (0, 1)	−0.8
Moderately frail	11 (31.4)	12 (34.3)	12 (34.3)	0.0 (0.8)	−0.3, 0.3	0 (−1, 1)	−0.1
Severely frail	22 (62.8)	3 (8.6)	10 (28.6)	−0.3 (0.9)	−0.7, 0.0	−1 (−1, 1)	0.8
Very severely frail	23 (65.7)	3 (8.6)	9 (25.7)	−0.4 (0.9)	−0.7, −0.1	−1 (−1, 1)	0.9
Terminally Ill	28 (80.0)	2 (5.7)	5 (14.3)	−0.7 (0.7)	−0.9, −0.4	−1 (−1, −1)	1.8
Hypoxia
88 < SpO2 ≤ 93%	4 (11.4)	9 (25.8)	22 (62.8)	0.5 (0.7)	0.3, 0.8	1 (0, 1)	−1.0
SpO2 <88%	3 (8.6)	6 (17.1)	26 (74.3)	0.7 (0.6)	0.4, 0.9	1 (0, 1)	−1.7
Hypotension and organ failure
MAP* <70 mmHg	2 (5.7)	12 (34.3)	21 (60.0)	0.5 (0.6)	0.3, 0.8	1 (0, 1)	−1.0
Dopamine ≤5 or Dobutamine (any dose)	2 (5.7)	13 (37.1)	20 (57.2)	0.5 (0.6)	0.3, 0.7	1 (0, 1)	−0.9
Dopamine >5, Epinephrine ≤0.1, or norepinephrine ≤0.1	4 (11.4)	12 (34.3)	19 (54.3)	0.4 (0.7)	0.2, 0.7	1 (0, 1)	−0.8
Dopamine >15, Epinephrine >0.1, or norepinephrine >0.1	7 (20.0)	11 (31.4)	17 (48.6)	0.3 (0.8)	0.0, 0.6	0 (0, 1)	−0.6
DIC**	13 (37.2)	11 (31.4)	11 (31.4)	0.0 (0.9)	−0.3, 0.3	0 (−1, 1)	0.7
Cardiac arrest	28 (80.0)	2 (5.7)	5 (14.3)	−0.7 (0.7)	−1, −0.4	−1 (−1, −1)	0.5

^* Mean Arterial Pressure.

^**Disseminated intravascular coagulation.